Business Description
Supriya Lifescience Ltd
ISIN : INE07RO01027
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.48 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 66.4 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 20.41 | |||||
Beneish M-Score | -1.69 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.3 | |||||
3-Year EBITDA Growth Rate | -31 | |||||
3-Year EPS without NRI Growth Rate | -32.6 | |||||
3-Year Book Growth Rate | -1.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 72.41 | |||||
9-Day RSI | 68.11 | |||||
14-Day RSI | 63.94 | |||||
6-1 Month Momentum % | 10.76 | |||||
12-1 Month Momentum % | 43.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.17 | |||||
Quick Ratio | 4.06 | |||||
Cash Ratio | 1.03 | |||||
Days Inventory | 164.52 | |||||
Days Sales Outstanding | 59.98 | |||||
Days Payable | 98.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.15 | |||||
Dividend Payout Ratio | 0.04 | |||||
Forward Dividend Yield % | 0.15 | |||||
5-Year Yield-on-Cost % | 0.15 | |||||
3-Year Average Share Buyback Ratio | -46.6 | |||||
Shareholder Yield % | 0.87 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.12 | |||||
Operating Margin % | 27.6 | |||||
Net Margin % | 20.88 | |||||
FCF Margin % | -5.67 | |||||
ROE % | 15.76 | |||||
ROA % | 13.83 | |||||
ROIC % | 16.56 | |||||
ROC (Joel Greenblatt) % | 27.59 | |||||
ROCE % | 21.49 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 27.81 | |||||
PE Ratio without NRI | 27.81 | |||||
Price-to-Owner-Earnings | 41.54 | |||||
PS Ratio | 5.81 | |||||
PB Ratio | 4.06 | |||||
Price-to-Tangible-Book | 4.07 | |||||
Price-to-Operating-Cash-Flow | 29.24 | |||||
EV-to-EBIT | 19.27 | |||||
EV-to-EBITDA | 17.61 | |||||
EV-to-Revenue | 5.68 | |||||
EV-to-FCF | -100.12 | |||||
Price-to-Graham-Number | 2.24 | |||||
Price-to-Net-Current-Asset-Value | 11.35 | |||||
Earnings Yield (Greenblatt) % | 5.19 | |||||
FCF Yield % | -0.98 | |||||
Forward Rate of Return (Yacktman) % | -10.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Supriya Lifescience Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 5,703.71 | ||
EPS (TTM) (₹) | 14.8 | ||
Beta | 0 | ||
Volatility % | 33.11 | ||
14-Day RSI | 63.94 | ||
14-Day ATR (₹) | 14.080394 | ||
20-Day SMA (₹) | 391.21 | ||
12-1 Month Momentum % | 43.9 | ||
52-Week Range (₹) | 231.05 - 423.5 | ||
Shares Outstanding (Mil) | 80.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Supriya Lifescience Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Supriya Lifescience Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Supriya Lifescience Ltd Frequently Asked Questions
What is Supriya Lifescience Ltd(BOM:543434)'s stock price today?
When is next earnings date of Supriya Lifescience Ltd(BOM:543434)?
Does Supriya Lifescience Ltd(BOM:543434) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |